BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11751611)

  • 61. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Suppression of protein kinase Cepsilon mediates 17beta-estradiol-induced neuroprotection in an immortalized hippocampal cell line.
    Jung ME; Watson DG; Simpkins JW
    J Neurochem; 2005 Nov; 95(3):745-55. PubMed ID: 16248886
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Estrogen regulates bcl-x expression in rat hippocampus.
    Stoltzner SE; Berchtold NC; Cotman CW; Pike CJ
    Neuroreport; 2001 Sep; 12(13):2797-800. PubMed ID: 11588579
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Progesterone-induced neuroprotection.
    Singh M
    Endocrine; 2006 Apr; 29(2):271-4. PubMed ID: 16785602
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo.
    Liu L; Zhao L; She H; Chen S; Wang JM; Wong C; McClure K; Sitruk-Ware R; Brinton RD
    Endocrinology; 2010 Dec; 151(12):5782-94. PubMed ID: 20943809
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.
    Pike CJ
    J Neurochem; 1999 Apr; 72(4):1552-63. PubMed ID: 10098861
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Estrogen protects primary cortical neurons from glutamate toxicity.
    Singer CA; Rogers KL; Strickland TM; Dorsa DM
    Neurosci Lett; 1996 Jul; 212(1):13-6. PubMed ID: 8823751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons.
    Goodman Y; Bruce AJ; Cheng B; Mattson MP
    J Neurochem; 1996 May; 66(5):1836-44. PubMed ID: 8780008
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.
    O'Neill K; Chen S; Brinton RD
    Exp Neurol; 2004 Jan; 185(1):63-80. PubMed ID: 14697319
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression.
    Jodhka PK; Kaur P; Underwood W; Lydon JP; Singh M
    Endocrinology; 2009 Jul; 150(7):3162-8. PubMed ID: 19325006
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Iodoacetate protects hippocampal neurons against excitotoxic and oxidative injury: involvement of heat-shock proteins and Bcl-2.
    Guo Z; Lee J; Lane M; Mattson M
    J Neurochem; 2001 Oct; 79(2):361-70. PubMed ID: 11677264
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An estrogen replacement therapy containing nine synthetic plant-based conjugated estrogens promotes neuronal survival.
    Zhao L; Chen S; Brinton RD
    Exp Biol Med (Maywood); 2003 Jul; 228(7):823-35. PubMed ID: 12876302
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of long-term treatment with 17 beta-estradiol and medroxyprogesterone acetate on water maze performance in middle aged female rats.
    Lowry NC; Pardon LP; Yates MA; Juraska JM
    Horm Behav; 2010 Jul; 58(2):200-7. PubMed ID: 20362580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors.
    Hussain R; El-Etr M; Gaci O; Rakotomamonjy J; Macklin WB; Kumar N; Sitruk-Ware R; Schumacher M; Ghoumari AM
    Endocrinology; 2011 Oct; 152(10):3820-31. PubMed ID: 21828184
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.
    Mafuvadze B; Liang Y; Besch-Williford C; Zhang X; Hyder SM
    Horm Cancer; 2012 Aug; 3(4):160-71. PubMed ID: 22569706
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm.
    Miyagawa K; Rösch J; Stanczyk F; Hermsmeyer K
    Nat Med; 1997 Mar; 3(3):324-7. PubMed ID: 9055861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Progesterone and neuroprotection.
    Singh M; Su C
    Horm Behav; 2013 Feb; 63(2):284-90. PubMed ID: 22732134
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Induction of apoptosis by metformin and progesterone in estrogen-induced endometrial hyperplasia in rats: involvement of the bcl-2 family proteins.
    Sahin E; Eraslan Sahin M; Dolanbay M; Ozcelik B; Akgun H; Saatci C
    Gynecol Endocrinol; 2018 May; 34(5):433-436. PubMed ID: 29179590
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease.
    Brinton RD; Chen S; Montoya M; Hsieh D; Minaya J
    Maturitas; 2000 Apr; 34 Suppl 2():S35-52. PubMed ID: 10915920
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of medroxyprogesterone acetate and clomiphene citrate on platelet function in menopausal women.
    Tepper R; Bar J; Goldberger S; Fuchs J; Beyth Y; Ovadia J
    Maturitas; 1996 May; 24(1-2):51-6. PubMed ID: 8794434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.